As shown in Figure 5A, the Ad-NDRG2 group that received injections at 2 × 109 PFU achieved a sustained and significant arrest of tumour growth (68% decrease in mean tumour volume on day 21 compared with Ad-LacZ group). This evidence concerns the gene NDRG2 and neoplasm.